Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02185521 · ClinicalTrials.gov registry record · NA
Hemodynamic Instability Index: The Impact to Care With a New Predictive Indicator
A NA study, sponsored by Philips Healthcare.
- Terminated
- Registry status
- NA
- Development phase
- 127
- Enrollment target
NCT02185521 is a NA study that was terminated before completion, run by Philips Healthcare. The registered enrollment target is 127 participants.
The verdict
NCT02185521, a NA study, was terminated before completion, sponsored by Philips Healthcare.
- TERMINATED
- Registry status
- NA
- Development phase
- 127 participants
- Enrollment target
Study Summary
Philips has developed a new algorithm, called Hemodynamic Instability Rules Based Advisor (HIRBA 2.0) system, for the prediction of hemodynamic instability in critically ill patients, who were not previously known to be at risk. This algorithm provides with the numerical index - Hemodynamic Instability Index (HII) and its trend which are calculated from existing real time data derived from patient's current hospital stay such as heart rate and blood pressure, labs, and Admission - Discharge- Transfer (ADT) data to help healthcare providers obtain information about patient's status and make clinical decisions. The aim of the study is to determine if the patient clinical information, displayed in the form of HII, can prompt possible patient hemodynamic status change and trigger earlier clinical care team response. We hypothesize that this real-time information on hemodynamic instability and earlier clinical decision making will lead to reduced length of stay (LOS) and ICU mortality relative to standard care practice. Study will also identify if the use of the Philips new algorithm called Hemodynamic Instability Rules Based Advisor (HIRBA 2.0) can improve outcomes for patients admitted to the intensive care units (ICUs). During this study, upon patient admission to the ICU clinical data collection will begin. Data that will be pulled during the study includes: vital signs, medications, reason for admission to the ICU, treatments that patient may receive. Research subjects will not be asked to do anything as far as specific activities expected to be accomplished during study participation. Subjects will be involved in the study only during their stay in ICU. HII information will be visible to clinicians, taking care of this patient only during his/ her stay in the study unit. Study team will collect patient information and have the ability to view the HII for subjects. Once patient leaves the ICU the study team will collect information on the remainder of patient's
Interventions
- OTHER patient assessment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2016-03-01 |
| Est. Completion | 2016-11-18 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02185521
The ClinicalTrials.gov registry entry for NCT02185521 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Philips Healthcare, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which patient assessment is the first listed.
NCT02185521 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02185521 about?
NCT02185521 is a clinical study titled "Hemodynamic Instability Index: The Impact to Care With a New Predictive Indicator". Philips has developed a new algorithm, called Hemodynamic Instability Rules Based Advisor (HIRBA 2.0) system, for the prediction of hemodynamic instability in critically ill patients, who were not previously known to be at risk. This algorithm provides with the numerical index - Hemodynamic Instabil...
What is the current status of trial NCT02185521?
This trial is currently terminated. It is a NA study. The enrollment target is 127 participants. The study started on 2016-03-01. Estimated completion is 2016-11-18.
What interventions are being tested in trial NCT02185521?
The interventions under investigation include: patient assessment (OTHER).
Who is sponsoring clinical trial NCT02185521?
This trial is sponsored by Philips Healthcare, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.